ONCOLYTICS BIOTECH
Oncolytics Biotech focuses the research and development efforts on the development of REOLYSIN, the cancer therapeutic. The product for human use, REOLYSIN is developed from the reovirus. The virus has been demonstrated to replicate in the tumour cells bearing an activated Ras pathway. The Ras protein is a regulator of cell growth and differentiation. It transmits signals from the cell's surface, through growth factor receptors, to downstream elements, which are in turn relayed to the nucleus. T... he transmission of signals from the cell surface to the cell's nucleus is referred to as the signal transduction. The wholly owned subsidiaries of the company include Oncolytics Biotech (Barbados) Inc. and Oncoltics Biotech (US) Inc. In April 2009, the Company completed the acquisition of an inactive private company. Oncolytics Biotech was founded on 1988 and is based in Calgary, Alberta, Canada.
ONCOLYTICS BIOTECH
Industry:
Biotechnology Health Care Medical Therapeutics Wellness
Founded:
1988-01-01
Address:
Calgary, Alberta, Canada
Country:
Canada
Website Url:
http://www.oncolyticsbiotech.com
Total Employee:
11+
Status:
Active
Contact:
403.670.7377
Email Addresses:
[email protected]
Total Funding:
80.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Garden of Alice
Garden of Alice offers a strategic direction in delivering products and therapeutics that help in nourishing the body and soul.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-21 | Oncolytics Biotech® Promotes Thomas C. Heineman, M.D., Ph.D., to Chief Medical Officer |
Official Site Inspections
http://www.oncolyticsbiotech.com Semrush global rank: 4.23 M Semrush visits lastest month: 2.77 K
- Host name: oncolytics.tempurl.host
- IP address: 149.28.195.92
- Location: San Jose United States
- Latitude: 37.3387
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95113
